Safety of six-month dual antiplatelet therapy after second-generation drug-eluting stent implantation: OPTIMA-C Randomised Clinical Trial and OCT Substudy

Byoung-Kwon Lee1, MD; Jung-Sun Kim2, MD; Oh-Hyun Lee1, MD; Pil-Ki Min1, MD; Young-Won Yoon1, MD; Bum-Kee Hong1, MD; Dong-Ho Shin2, MD, MPH; Tae-Soo Kang3, MD; Byung Ok Kim4, MD; Deok-Kyu Cho5, MD; Dong Woon Jeon6, MD; Sung-Ill Woo7, MD; Seonghoon Choi8, MD; Yong Hoon Kim9, MD; Woong-Chol Kang10, MD; Seunghwan Kim2, MD; Byeong-Keuk Kim2, MD; Myeong-Ki Hong2, MD; Yangsoo Jang2, MD; Hyuck Moon Kwon1*